• OPEN AN ACCOUNT
Indian Indices
Nifty
24,870.10 -213.65
(-0.85%)
Sensex
81,306.85 -693.86
( -0.85%)
Bank Nifty
55,149.40 -606.05
( -1.09%)
Nifty IT
35,440.85 -283.05
( -0.79%)
Global Indices
Nasdaq
45,658.64 852.13
(1.90%)
Dow Jones
6,488.44 97.27
(1.52%)
Hang Seng
42,587.47 -22.70
(-0.05%)
Nikkei 225
9,321.40 12.20
(0.13%)
Forex
USD-INR
87.05 -0.06
(-0.07%)
EUR-INR
101.38 -0.20
(-0.20%)
GBP-INR
117.29 -0.32
(-0.27%)
JPY-INR
0.59 0.00
(0.13%)

EQUITY - MARKET SCREENER

Anuh Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
506260
INE489G01022
32.5296137
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ANUHPHR
19.65
905.82
EPS(TTM)
Face Value()
Div & Yield %
4.6
5
0.83
 

jm financial ltd
Ashok Leyland Ltd - Board Meeting Intimation for Considering And Approval Of Standalone And Consolidated Audited Financials For The Year Ended March 31 2025 And Recommendation Of Final Dividend If Any For The Approval Of The Shareholders
May 08,2025
Ashok Leyland Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve standalone and consolidated audited financials for the year ended March 31 2025 and recommendation of final dividend if any for the approval of the shareholders